^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SYN-27M

i
Other names: SYN-27M, IMM27M, IMM-27M, IMM 27M, SYN27M, SYN 27M
Associations
Trials
Company:
ImmuneOnco Biopharma, Instil Bio
Drug class:
CTLA4 inhibitor
Associations
Trials
over1year
Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor (clinicaltrials.gov)
P1, N=16, Recruiting, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | Not yet recruiting --> Recruiting | Trial completion date: Aug 2023 --> Aug 2024 | Trial primary completion date: Apr 2023 --> Aug 2023
Enrollment open • Trial completion date • Trial primary completion date • Metastases
|
SYN-27M